
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CCL5 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-CCL5.
CCL5 / RANTES Antibody (clone OTI2A7)
Primary AntibodyLSBio Guarantee
| Antibody: | Mouse Monoclonal |
| Applications: | Western Blot |
| Reactivity: | Human |
| Format: | Liquid |
$443.00each
Catalog Number: LS-C339935-100
Catalog Number: LS-C339935
For bulk orders or custom formulations:
Request a QuoteOverview
- Description
- RANTES antibody LS-C339935 is an unconjugated mouse monoclonal antibody to human RANTES (CCL5). Validated for WB.
- Application
- WB
- Reactivity
- Hu
- Intended Use
- Research Use Only
- Guarantees
- This antibody carries the LSBio 100% Guarantee. ✓
- Category
- Antibodies > Primary Antibodies > Monoclonal Antibodies
- Alternative Names
- Chemokine (C-C motif) ligand 5 | CCL5 | D17S136E | EoCP | T-cell specific protein p288 | SCYA5 | SISd | T cell-specific protein P228 | Beta-chemokine RANTES | C-C motif chemokine 5 | RANTES | SIS-delta | Small-inducible cytokine A5 | T-cell-specific protein RANTES | TCP228
- Recommended Dilution: WB
- 1:2000
- UniProt Number
- P13501
- NCBI GenBank
- NM_002985 | NP_002976.2
- SwissProt
- P13501
Target
- Target
- Human CCL5 / RANTES
- Antigen Species
- Human
- Epitope
- Human CCL5 / RANTES
- Gene Name
- CCL5
Antibody
- Host Species
- Mouse
- Clonality
- Monoclonal
- Clone
- OTI2A7
- Isotype
- IgG1
Immunogen
- Immunogen
- Full length human recombinant protein of human CCL5 (NP_002976) produced in HEK293T cell.
- Immunogen Type
- Full-Length Recombinant Protein
Format
- Conjugate/Label
- Unconjugated
- Format
- Liquid
- Formulation
- PBS, pH 7.3, 0.02% Sodium Azide, 50% Glycerol, 1% BSA
- Concentration
- 1 mg/mL
- Volume
- 100 Microliter
- Preservative
- Yes
- Purification Method
- Affinity Purified
Storage & Handling
- Storage Conditions
- Store at -20°C. Avoid freeze-thaw cycles.
- Recommended Storage Buffer
- PBS
